Dcvc Opportunity Fund Ii Gp, LLC Recursion Pharmaceuticals, Inc. Transaction History
Dcvc Opportunity Fund Ii Gp, LLC
- $19.3 Million
- Q3 2025
A detailed history of Dcvc Opportunity Fund Ii Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Dcvc Opportunity Fund Ii Gp, LLC holds 3,951,141 shares of RXRX stock, worth $16.4 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
3,951,141
Previous 3,951,141
-0.0%
Holding current value
$16.4 Million
Previous $20 Million
3.56%
% of portfolio
100.0%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
362Shares Held
301MCall Options Held
7.71MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA39.8MShares$165 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$139 Million1.15% of portfolio
-
Baillie Gifford & CO24MShares$99.3 Million0.09% of portfolio
-
State Street Corp Boston, MA18.3MShares$75.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$71.7 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $747M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...